Trials / Unknown
UnknownNCT04575545
Prevalence of COVID-19 Infection in a Cohort of Patients Infected by the HIV and Patients Taking PrEP
Prevalence of COVID-19 Infection in a Cohort of Patient Infected by the HIV and Patients Taking PrEP Pre-exposure Prophylaxis
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 600 (estimated)
- Sponsor
- Hôpital Européen Marseille · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to assess seroprevalence of COVID-19 infection in a cohort of HIV + patients and in a cohort of patients taking PrEP by emtricitabine / tenofovir.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Serology test for COVID-19 | ELISA test |
Timeline
- Start date
- 2020-10-01
- Primary completion
- 2021-03-01
- Completion
- 2022-04-01
- First posted
- 2020-10-05
- Last updated
- 2020-10-05
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT04575545. Inclusion in this directory is not an endorsement.